-
-
-
-
-
-
-
Cardiol Therapeutics raises $13.5 million in bought deal financing
-
-
-
-
-
-
-
Cardiol Therapeutics receives U.S. patent allowance for heart drugs through 2040
-
-
-
-
-
-
-
Cardiol Therapeutics to Participate in Fireside Chat at Canaccord Genuity's 45th Annual Growth Conference
-
-
-
-
-
-
-
Cardiol Therapeutics to Webcast Virtual Annual General Meeting of Shareholders on May 28th at 4:30 p.m. EDT
-
-
-
-
-
-
-
Cardiol Therapeutics Announces Year-End 2024 Update on Operations
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on Cardiol Therapeutics (CRDL)
-
-
-
-
-
-
-
Cardiol Therapeutics Announces Pricing of Public Offering of Common Shares
-
353,174 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

